(Stroke. 2000;31:920.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology, University of Münster, Münster, Germany (D.W.D., R.J., R.T., E.B.R.), and Schering AG, Berlin, Germany (S.W.).
Correspondence and reprint requests to Dr Dirk W. Droste, Klinik und Poliklinik für Neurologie der WWU Münster, Albert-Schweitzer-Str 33, D-48129 Münster, Germany. E-mail droste2{at}uni-muenster.de
| Abstract |
|---|
|
|
|---|
MethodsWe investigated 50 temporal windows of 44 patients with
ipsilateral high-grade (
70%) ICA stenosis or occlusion and
insufficient native transtemporal insonation conditions
before and after the application of the echo enhancer Levovist with an
infusion pump.
ResultsCompared with the precontrast scans, echocontrast allowed for more segments to be evaluated by pulsed Doppler sonography (P<0.0001) and for longer lumen segments to be displayed on color mode (P<0.0001). Also, collateral flow via the anterior and posterior communicating artery could be demonstrated in 25 and 32 scans, respectively, compared with only 1 demonstration of each collateral pathway before the application of contrast medium (both P<0.0001). Similarly, with the help of contrast medium, flow velocity in the middle cerebral artery could be measured in 45 cases compared with only 26 cases before contrast was applied (P<0.0001).
ConclusionsIn patients with poor precontrast visualization of intracranial arteries, echocontrast-enhanced TCCD is very helpful in the assessment of intracranial collateral pathways recruited downstream to ICA stenoses and occlusions.
Key Words: carotid artery diseases contrast media ultrasonography, Doppler, duplex
| Introduction |
|---|
|
|
|---|
In patients with extracranial high-grade stenoses and occlusions, this technique is capable of demonstrating collateral blood flow within the circle of Willis and its branches to identify patients at low versus high hemodynamic risk.6 7 8 9 10 11 12 13 By doing this, TCCD adds further details to the quantification and prognostic evaluation of extracranial carotid artery disease.14 Occasionally, TCCD is made difficult by an insufficient temporal bone window, by an unfavorable insonation angle, by low flow volume or low flow velocity in single arterial segments, or by a combination of these factors. Echocontrast agents able to survive pulmonary and capillary transit have recently been developed to improve the echogenicity of the flowing blood and to overcome these restrictions. Levovist (Schering AG) is the most widely used echocontrast agent in neurosonology. After preparation, Levovist is a suspension of air-filled microbubbles with a palmitic acid layer adherent to galactose microgranules. The median diameter of these microbubbles is 3 µm. Presently, attempts are made to prolong the echocontrast agents diagnostic time window by its continuous intravenous infusion.
In the present study we describe and quantify the benefit of echocontrast enhancement in assessing the collateral supply downstream to an internal carotid artery (ICA) high-grade stenosis or occlusion in patients with poor precontrast insonation conditions. A new type of application was used, namely, continuous infusion by means of a pump.
| Subjects and Methods |
|---|
|
|
|---|
70%) ICA stenosis or occlusion. Four patients had
intracranial high-grade ICA stenosis. Sixteen arteries were
occluded and the remaining 30 arteries showed extracranial
stenosis. There were 13 women and 31 men, aged from 35 to 85 years (mean 63 years). There were 8 smokers and 10 diabetics. Twenty-three individuals were hypertensive, and 17 suffered from hyperlipidemia. Twenty-seven patients had suffered a stroke, 4 patients a transient ischemic attack, 2 transient monocular blindness, and 1 optic nerve ischemia on the side of the carotid artery under investigation. The time span from the ischemic event to the investigation varied from hours to 11 years.
Both the native and echocontrast-enhanced investigations were continuously recorded onto video tapes for offline analysis. Diagnostically relevant pictures were also printed out in black and white or color.
One 4-g vial of the echo enhancer Levovist (11 mL suspension) was applied in a concentration of 400 mg/mL using an infusion pump with a continuous infusion rate of 2.5 mL/min.
The precontrast investigations were carried out with a low pulse repetition frequency on color mode, thus allowing for slow flow velocities or flow in arterial segments with a bad insonation angle to be displayed. In this setting, aliasing occurred and the direction information was lost on color mode. In the enhanced investigation, the pulse repetition frequency could usually be increased due to the stronger signal. Immediately after the investigation, the presence or absence of a diagnostic benefit of the investigation was recorded in written form. Tapes were subjected to an offline analysis that included the recording of the following 16 parameters during both the precontrast and postcontrast conditions: the length of the visible color-coded blood flow column of (1) the MCA main stem, (2) the A1 segment of the ipsilateral anterior cerebral artery (ACA), (3) the A1 segment of the contralateral ACA, (4) the ipsilateral PCoA, (5) the P1 segment of the ipsilateral posterior cerebral artery (PCA), (6) the P2 segment of the ipsilateral PCA, (7) the length of the P1 segment of the contralateral PCA; (8 to 14) the ability to obtain a pulsed-wave Doppler spectrum in the above arterial segments and (15) in the ACoA, and (16) the number of MCA-branches identifiable as color-coded signals. The length of the ACoA was not assessed, because it cannot unequivocally be discriminated from the ACAs on color mode. On Doppler spectral mode, however, it can be pinpointed due to a frequent change in velocity and to its median location.
Intra-arterial digital subtraction angiographies were available for 13 ICAs investigated selectively, including images of the intracranial anterior (n=13) and posterior (n=11) circulation. In 5 further cases only the extracranial arteries were displayed on the angiograms.
The nonparametric Wilcoxon matched-pairs signed rank test was performed to test the effect of echocontrast enhancement on each of the 16 parameters under investigation.
| Results |
|---|
|
|
|---|
|
All the probability values for the single 16 precontrast and postcontrast comparisons were P<0.0001.
There were 25 demonstrations of collateral flow via the ACoA and 32 of collateral flow via the PCoA. In 19 investigations, both pathways were patent. In 45 cases, flow velocity in the MCA could be measured after contrast compared with only 26 cases before contrast was applied (P<0.0001).
In the patients also investigated by intra-arterial angiography, the ultrasound diagnosis of presence or absence of collateral flow was confirmed (7 ACoAs, 9 PCoAs).
The investigations did not cause any side effects. The Figure
demonstrates the TCCD findings of an illustrative case through the left
temporal window of a patient with ICA occlusion before and after
contrast application. Before contrast was applied, the MCA, both A1
segments, and part of the PCA could be visualized only with a low pulse
repetition frequency (so-called slow-flow setting). After contrast
application, the pulse repetition frequency could be raised, and the
whole ipsilateral circle of Willis could be visualized, including the
collateral supply via both communicating arteries.
|
| Discussion |
|---|
|
|
|---|
By means of native TCCD scans, ie, scans without echocontrast
enhancement, a Doppler spectrum of the ipsilateral MCA or of the P2
segment of the ipsilateral PCA could be obtained in only about half of
the patients. The other arterial segments could be
recorded in only 8% to 18% of the cases of the cohort. After the
administration of contrast, however, a spectral Doppler signal
could be obtained in 76% to 92% of the investigations and the ACoA
and PCoA could be recorded in 50% and 64% of the investigations,
respectively. A significantly higher number of arteries and longer
arterial segments could be visualized on color mode with
the use of contrast medium. The results of the present study are in
accord with the recent literature. In a native TCCD study with a
patient cohort comparable to ours except for adequate temporal bone
windows in their study, Baumgartner et al7 found an ACoA
to be present angiographically in 63% and a PCoA in 42%.
Sensitivity of unenhanced TCCD in their study was 100% for the ACoA
and 64% for the PCoA. The sensitivity of echocontrast-enhanced TCCD of
100% for the detection of both collateral pathways in comparison to
the angiographic findings underlines the benefit of this
diagnostic procedure. This is particularly true for the
PCoA, which in most cases shows a large, unfavorable insonation angle
(see the Figure
). The authors are aware of the overestimation of
collateral pathways during intra-arterial angiography
because of the pressure used to inject the contrast agent.
Demonstration or lack of collateral flow in the circle of Willis in patients with ICA stenosis and the velocity and pulsatility of the Doppler flow spectrum in the ipsilateral MCA are parameters for proper classification of the ICA stenosis (see below) and help in estimation of the hemodynamic risk in the dependent hemisphere. TCCD allows the continuous visualization of the color-coded blood flow column in several arteries at the same time and thus facilitates spatial orientation and correct placement of the Doppler sample volume in the large basal arteries. Compression tests of the carotid artery to show flow increase, flow decrease, or flow reversal in order to indirectly demonstrate collateral supply bear a low though avoidable risk of embolization.15 16 The visualization of the communicating arteries with TCCD renders these tests unnecessary.
The presence of collateral flow indicates that an ICA stenosis is high grade. In contrast, the absence of collateral flow in a given ICA stenosis otherwise classified as high grade in combination with a marked side-to-side difference in the MCA spectral Doppler signals identifies a patient as being at an increased hemodynamic risk to develop ischemic opthalmopathy and cerebral borderzone infarctions.9 When undergoing carotid endarterectomy, these patients are particularly vulnerable during carotid artery cross-clamping.10 11 12 13 The knowledge of this situation may lead to the use of a shunt during carotid endarterectomy and to special attention by the anesthesiologist to avoid drops in blood pressure during any surgical intervention. In acute stroke patients with normal or low blood pressure, the therapeutic raising of blood pressure must be considered in these cases with poor collateral supply in order to avoid stroke progression or further hemodynamic infarction. A recent SPECT study suggests that these patients are also at an increased risk of developing a so-called "malignant MCA infarction."17 In these particular patients, close-meshed clinical and CT follow-ups are mandatory so as not to miss the time for life-saving decompressive hemicraniectomy.18 19
Echocontrast-related side effects were rare, and if present at all, were transient and minor.20 MRI, MR angiography, CT angiography, or intra-arterial angiography are potentially more harmful. In a review of 8 prospective studies, 1% arteriography-related disabling strokes and 0.06% deaths in a total of 2227 cerebral arteriographies were described.21 MRI, MR angiography, CT angiography, and intra-arterial angiography are expensive and not yet generally available. Ultrasound is a reliable, cheap, and easily repeatable bedside procedure. These are further arguments for the use of diagnostic ultrasound supported, if necessary, by echocontrast enhancement.
In summary, echocontrast agents are helpful in the assessment of suspected and definite intracranial collateral supply distally to ICA stenoses and occlusions in patients with poor precontrast investigational conditions.
| Acknowledgments |
|---|
Received August 5, 1999; revision received January 27, 2000; accepted January 27, 2000.
| References |
|---|
|
|
|---|
2. Baumgartner RW, Mathis J, Sturzenegger M, Mattle HP. A validation study on the intraobserver reproducibility of transcranial color-coded duplex sonography velocity measurements. Ultrasound Med Biol. 1994;20:233237.[Medline] [Order article via Infotrieve]
3.
Kaps M, Seidel G, Bauer T, Behrmann B. Imaging of the
intracranial vertebrobasilar system using color-coded ultrasound.
Stroke. 1992;23:15771582.
4.
Goertler M, Kross R, Baeumer M, Jost S, Grote R, Weber
S, Wallesch CW. Diagnostic impact and prognostic relevance
of early contrast-enhanced transcranial color-coded duplex
sonography in acute stroke. Stroke. 1998;29:955962.
5. Nabavi DG, Droste DW, Schulte Altedorneburg G, Kemeny V, Panzica M, Weber S, Ringelstein EB. Diagnostic benefit of echocontrast enhancement for the insufficient transtemporal bone window. J Neuroimaging. 1999;9:102107.[Medline] [Order article via Infotrieve]
6.
Klötzsch C, Popescu O, Berlit P. Assessment of
the posterior communicating artery by transcranial
color-coded duplex sonography. Stroke. 1996;27:486489.
7. Baumgartner RW, Baumgartner I, Schroth G. Diagnostic criteria for transcranial colour-coded duplex sonography evaluation of cross-flow through the circle of Willis in unilateral obstructive carotid artery disease. J Neurol. 1996;243:516521.[Medline] [Order article via Infotrieve]
8. Baumgartner RW, Baumgartner I, Mattle HP, Schroth G. Transcranial color-coded duplex sonography in the evaluation of collateral flow through the circle of Willis. AJNR Am J Neuroradiol. 1997;18:127133.[Abstract]
9. Ringelstein EB, Weiller C, Weckesser M, Weckesser S. Cerebral vasomotor reactivity is significantly reduced in low-flow as compared to thromboembolic infarctions: the key role of the circle of Willis. J Neurol Sci. 1994;121:103109.[Medline] [Order article via Infotrieve]
10.
Schneider PA, Ringelstein EB, Rossman ME, Dilley RB,
Sobel DF, Otis SM, Bernstein EF. Importance of cerebral collateral
pathways during carotid endarterectomy.
Stroke. 1988;19:13281334.
11.
Schneider PA, Rossman ME, Bernstein EF, Torem S,
Ringelstein EB, Otis SM. Effect of internal carotid artery occlusion on
intracranial hemodynamics: transcranial
Doppler evaluation and clinical correlation. Stroke. 1988;19:589593.
12. Lopez Bresnahan MV, Kearse LA Jr, Yanez P, Young TI. Anterior communicating artery collateral flow protection against ischemic change during carotid endarterectomy. J Neurosurg. 1993;79:379382.[Medline] [Order article via Infotrieve]
13.
Doblar DD, Plyushcheva NV, Jordan W, McDowell H.
Predicting the effect of carotid artery occlusion during carotid
endarterectomy: Comparing transcranial
Doppler measurements and cerebral angiography. Stroke. 1998;29:20382042.
14. de Bray JM, Glatt B. Quantification of atheromatous stenosis in the extracranial internal carotid artery. Cerebrovasc Dis. 1995;5:414426.
15. Mast H, Ecker S, Marx P. Cerebral ischemia induced by compression tests during transcranial Doppler sonography. Clin Investig. 1993;71:4648.[Medline] [Order article via Infotrieve]
16. Khaffaf N, Karnik R, Winkler WB, Valentin A, Slany J. Embolic stroke by compression maneuver during transcranial Doppler sonography. Stroke. 1994;25:10561057.[Abstract]
17.
Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse
S, Schneider D. 99(m)technetium-ethyl-cysteinate-dimer
single-photon emission CT can predict fatal ischemic brain
edema. Stroke. 1998;29:25562562.
18.
Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH,
Jansen O, Hacke W. Early hemicraniectomy in patients with complete
middle cerebral artery infarction. Stroke. 1998;29:18881893.
19. Berrouschot J, Sterker M, Bettin S, Koster J, Schneider D. Mortality of space-occupying ("malignant") middle cerebral artery infarction under conservative intensive care. Intensive Care Med. 1998;24:620623.[Medline] [Order article via Infotrieve]
20. Gebel M, Caselitz M, Bowen-Davies PE, Weber S. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 A (Levovist) for Doppler signal enhancement in the portal vascular system. Ultraschall Med. 1998;19:148156.[Medline] [Order article via Infotrieve]
21.
Hankey GJ, Warlow C, Sellar RJ. Cerebral
angiographic risk in mild cerebrovascular disease. Stroke. 1990;21:209222.
This article has been cited by other articles:
![]() |
E. R. Bates, C. J. D. Babb, D. E. Casey, C. U. Cates, G. R. Duckwiler, T. E. Feldman, W. A. Gray, K. Ouriel, E. D. Peterson, K. Rosenfield, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting) Vascular Medicine, February 1, 2007; 12(1): 35 - 83. [PDF] |
||||
![]() |
American Society of Interventional & Therapeutic N, Society for Cardiovascular Angiography and Interve, Society for Vascular Medicine and Biology, Society of Interventional Radiology, E. R. Bates, J. D. Babb, D. E. Casey Jr, C. U. Cates, G. R. Duckwiler, T. E. Feldman, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting) J. Am. Coll. Cardiol., January 2, 2007; 49(1): 126 - 170. [Full Text] [PDF] |
||||
![]() |
P. Zunker, H. Wilms, J. Brossmann, D. Georgiadis, S. Weber, and G. Deuschl Echo Contrast-Enhanced Transcranial Ultrasound: Frequency of Use, Diagnostic Benefit, and Validity of Results Compared With MRA Stroke, November 1, 2002; 33(11): 2600 - 2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schulte-Altedorneburg, D. W. Droste, S. Felszeghy, L. Csiba, V. Popa, K. Hegedus, J. Kollar, L. Modis, and E. B. Ringelstein Detection of Carotid Artery Stenosis by In Vivo Duplex Ultrasound: Correlation With Planimetric Measurements of the Corresponding Postmortem Specimens Stroke, October 1, 2002; 33(10): 2402 - 2407. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Deklunder Role of ultrasound and contrast-enhanced ultrasound in patients with cerebrovascular disease Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C51 - C55. [Abstract] [PDF] |
||||
![]() |
R. A. Boyajian, S. M. Otis, D.W. Droste, R. Jurgens, R. Tietje, E.B. Ringelstein, and S. Weber Continuous Infusion Versus Bolus Injection Of Ultrasound Contrast Agents in Vascular Doppler Flow Imaging Response Stroke, September 1, 2000; 31 (9): 2266 - 2278. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |